Itron (ITRI) Tops Q1 EPS by 9c, Offers FY Guidance
Get Alerts ITRI Hot Sheet
Price: $94.39 -0.03%
Revenue Growth %: +17.1%
Financial Fact:
Other income (expense), net: 707K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +17.1%
Financial Fact:
Other income (expense), net: 707K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Itron (NASDAQ: ITRI) reported Q1 EPS of $0.52, $0.09 better than the analyst estimate of $0.43. Revenue for the quarter came in at $520 million versus the consensus estimate of $547.37 million.
GUIDANCE:
Itron sees FY2021 EPS of $2.30-$2.70, versus the consensus of $2.28.
- During the first quarter, Itron completed convertible note and equity offerings to accelerate de-levering and improve strategic and balance sheet flexibility. The completion of these transactions and use of proceeds resulted in changes to the average diluted shares outstanding and interest expense expected for the full year, which impact our non-GAAP EPS guidance range provided on February 24, 2021.
- On February 24, 2021, Itron provided full year 2021 non-GAAP EPS guidance in a range of $2.15 to $2.55, with a midpoint of $2.35. That guidance assumed diluted weighted average shares outstanding of approximately 41 million and non-GAAP interest expense of approximately $36 million. Restating that guidance for the impact of the capital markets transactions results in an increase of Non-GAAP EPS expectations of approximately $0.15 per share. This assumes diluted weighted average shares outstanding of 44.7 million and non-GAAP interest expense of approximately $16 million. The resulting restated non-GAAP EPS range for 2021 is $2.30 to $2.70, with a midpoint of $2.50 per share.
- A reconciliation of forward-looking non-GAAP diluted EPS to the GAAP diluted EPS has not been provided because we are unable to predict with reasonable certainty the potential amount or timing of restructuring and acquisition and integration related expenses and their related tax effects without unreasonable effort. These items are uncertain, depend on various factors and could have a material impact on GAAP results for the guidance period.
For earnings history and earnings-related data on Itron (ITRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
- Associated Banc-Corp (ASB) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!